StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 1 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Recs

0
Player Avatar defridgerator (< 20) Submitted: 7/18/2012 5:55:25 PM : Outperform Start Price: $1.79 STEM Score: +0.82

The last stock I add to MYCAPS based on another user's predictions - all I gotta say. Will drop this stock from caps list as soon as my minimum 7 day is met.

Featured Broker Partners


Advertisement